Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hemodialysis/крварење

Веза се чува у привремену меморију
Страна 1 од 5265 резултати

Testing the outcome score of spontaneous intracerebral haemorrhage in haemodialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The aim of this study is to determine the predictive value of the spontaneous intracerebral haemorrhage (ICH) outcome score (which we described previously) in haemodialysis (HD) patients who develop spontaneous ICH. The validation cohort consisted of all HD patients with spontaneous ICH presenting

Dialysis-induced worsening of cerebral edema in intracranial hemorrhage: a case series and clinical perspective.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Intracranial hemorrhage (ICH) is not an uncommon complication of end-stage renal disease (ESRD), and may be complicated by cerebral edema. Hemodialysis (HD) may induce rapid osmolar and fluid shifts, increasing brain water content with the potential to worsen cerebral edema. The dangers

Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Whether to anticoagulate dialysis patients with atrial fibrillation is a common clinical dilemma with limited high-quality data to inform decision-making. While the efficacy and safety of anticoagulation for stroke prevention in dialysis patients with atrial fibrillation has long been debated and

Performance of bleeding risk scores in dialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to

Experience with ulcerated, bleeding autologous dialysis fistulas.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE The incidence of ulcerated, bleeding, autologous, hemodialysis fistulas has been felt to be increasing in recent years. This review was undertaken to examine our experience with patients who presented with episodes of spontaneous bleeding in the presence of an ulcerated lesion over their

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Patients on chronic hemodialysis often have acquired coagulopathy that can aggravate bleeding from puncture site after needle extraction. Chitosan-based pads have been reported to accelerate hemostasis even in the presence of coagulopathy. The aim of this study was to evaluate the

Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Bleeding time, blood loss and platelet retention by glass beads, measured by standardized techniques, were significantly altered in a group of 30 non-thrombocytopenic patients with chronic renal failure undergoing maintenance haemodialysis. Bleeding time or blood loss did not correlate with platelet

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Patients with atrial fibrillation who receive dialysis are at a high risk of ischemic stroke. The role of warfarin in mitigating this risk in patients with atrial fibrillation who receive dialysis is uncertain. Our objective was to examine the safety and efficacy of warfarin in patients who have

Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Blood loss from the access cannulation site during hemodialysis (HD) treatment is inevitable. Nevertheless, during HD, excessive blood loss from the cannulation site is not uncommon. The clinical characteristics associated with it and whether such blood loss could impact on patient outcomes is

Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Our group has previously reported that excessive vascular access bleeding during dialysis treatment in stable hemodialysis (HD) patients was associated with anemia and may indicate poorer health. The association between excessive blood loss from access cannulation site and clinical outcomes was

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Current observational studies on warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results. RESULTS We conducted a population-based retrospective cohort study of patients aged ≥65 years admitted to a hospital

Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present paper describes a case of hemorrhagic cholecystitis in a patient on maintenance dialysis. The patient presented with right upper quadrant abdominal pain. Computed tomography revealed swelling of the gallbladder, high- and isodensity contents of the gallbladder, and high-density stone in

Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Acute kidney injury requiring renal replacement therapy occurs in up to 10% of all intensive care unit patients. Those who are hemodynamically unstable are often treated with continuous renal replacement therapy requiring continuous anticoagulation of the extracorporeal circuit. This is usually

A Multicenter Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND In 2014, the United States Food and Drug Administration approved a labeling change for apixaban to include recommendations for patients with severe renal impairment and patients with end-stage renal disease (ESRD) on hemodialysis (HD), though these recommendations are largely based on

Spontaneous renal hemorrhage in hemodialysis patients.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Dialysis patients have a tendency to bleed, and clinicians sometimes encounter cases with a significant amount of spontaneous hemorrhage. We herein report two cases of spontaneous renal hemorrhage in hemodialysis patients. CASE 1: A 70-year-old male who had received hemodialysis for 8 years
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge